Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT06557057
Status
Recruiting
Apply to this trial

Conditions

  • HER2-Positive Breast Carcinoma

Eligibility Criteria

Sex
FEMALE
Age
N/A - N/A
Healthy Volunteers
Accepted

Interventions

  • Non-Interventional Study — OTHER
    Non-Interventional Study

Study Details

This study assesses the effect of hormone directed treatment for breast cancer on glucose metabolism.

Key Dates

Start date
Nov 16, 2023
Status verified
Mar 2026
Primary completion
Dec 1, 2026
Completion
Dec 1, 2026

Study Design

Enrollment
66 participants (estimated)

Arms

  • Arm: Observational
    Patients undergo blood sample collection, glucose testing, DEXA scan to measure body composition, complete a questionnaire and have their medical records reviewed on study.

Primary Outcome Measure

Disposition Index (DI) [ Time Frame: Baseline; up to 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905
Clinical Trials Referral Office
[email protected]
855-776-0015
Kalpana Muthusamy, MBBS, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By research site
Mayo Clinic in Rochester· Rochester, MN

Related Studies